Section I
Crisis & Emergency Response

(Cognitive Aids + Cart Readiness)

SECTION I: TABLE OF CONTENTS

Crisis & Emergency Response (Cognitive Aids + Cart Readiness)

  • I1. Malignant hyperthermia (MH) policy + MH cart checklist
  • I2. LAST policy + lipid rescue dosing card
  • I3. Anaphylaxis policy
  • I4. Hemorrhage / Massive transfusion escalation policy
  • I5. Difficult/failed airway policy (adult/peds)
  • I6. Peri-arrest / code blue in OR/NORA/PACU policy
  • I7. OR fire / laser / oxygen-enriched environment safety policy
  • I8. Post-event debriefing policy + documentation
I1

POLICY: Malignant Hyperthermia (MH) Crisis Response + MH Cart Readiness

To ensure rapid recognition and standardized management of malignant hyperthermia (MH) in any anesthetizing location (OR/NORA/PACU-equivalent), including immediate availability and readiness of an MH cart, timely administration of dantrolene, supportive treatment (hyperventilation, cooling, treatment of acidosis/hyperkalemia), escalation pathways, and post-event care—supporting standardized perioperative safety processes. (istitlaa.ncc.gov.sa)

Applies to all anesthesia professionals, perioperative staff, PACU staff, and procedural teams in OR, NORA, and any area where triggering agents may be administered. (mhaus.org)

  • MH: A life-threatening pharmacogenetic hypermetabolic crisis triggered by volatile anesthetics and/or succinylcholine, requiring immediate treatment. (mhaus.org)
  • MH Cart: A dedicated emergency cart stocked per MH crisis recommendations, including dantrolene formulation-appropriate supplies and sterile water for reconstitution. (mhaus.org)
  • MHAUS Hotline: 24/7 MH expert support resource (as published by MHAUS). (mhaus.org)
  • 4.1 The facility shall maintain an MH crisis protocol as a cognitive aid available at point of care in all anesthetizing locations. (mhaus.org)
  • 4.2 An MH cart (or immediate access MH kit for remote sites) shall be available and ready for use at all times where MH can occur. (mhaus.org)
  • 4.3 Staff shall be trained and drilled to execute MH crisis roles, mixing/administering dantrolene and performing supportive management. (Anesthesia Patient Safety Foundation)
  • 4.4 Any MH event/near-miss requires documentation, incident reporting, and structured debriefing per Policy I8. (PMC)

5.1 Cognitive Aid Location

Post MH algorithm/checklist in: every OR core area, anesthesia workroom, NORA control points, PACU, and inside the MH cart top drawer. (mhaus.org)

5.2 MH Cart Readiness (Checklist + Checking Frequency)

  • A. Minimum Cart Drugs/Supplies (stock based on formulation):
    • Dantrolene: stock minimum quantities consistent with MHAUS recommendations (e.g., 36 vials of 20 mg formulation or 3 vials of 250 mg formulation). (mhaus.org)
    • Sterile water for injection (no bacteriostatic agent) stored with dantrolene (for reconstitution volumes per formulation). (mhaus.org)
    • Sodium bicarbonate 8.4%, dextrose 50%, calcium chloride 10%, regular insulin, antiarrhythmic option consistent with local ACLS approach, and refrigerated cold saline for IV cooling. (mhaus.org)
  • B. Readiness Checks:
    • Daily: seal intact, cart present in designated location, critical expiry check for dantrolene, oxygen/suction access confirmed.
    • Weekly/Monthly (local choice): full inventory, refrigeration items verified, sterile water quantity verified, mixing syringes/tubing present, cognitive aid present. (Anesthesia Patient Safety Foundation)
    • After any use: immediate restock, replacement of opened items, and re-sealing with documented return-to-service.

5.3 MH Crisis Response (Minimum Standard Steps)

  • Call for help and announce “MH CRISIS,” activate emergency response escalation. (mhaus.org)
  • Stop triggering agents and switch to 100% oxygen with hyperventilation using a clean circuit and high fresh-gas flows. (mhaus.org)
  • Administer dantrolene promptly (initial dosing per MHAUS guidance; repeat as needed within recommended maximum considerations). (mhaus.org)
  • Treat acidosis, hyperkalemia, dysrhythmias, and maintain urine output as per MH crisis guidance (avoid contraindicated drugs as per MH guidance). (mhaus.org)
  • Active cooling when core temperature is elevated/rapidly rising, and stop cooling when temperature reduces below target thresholds per MH crisis guidance. (mhaus.org)
  • Labs/monitoring: ABG/VBG, electrolytes, CK, coagulation as clinically indicated; continuous monitoring and preparation for ICU transfer. (mhaus.org)
  • Post-crisis: ICU monitoring and continued management per MH crisis recommendations; document event thoroughly and initiate debrief. (mhaus.org)
  • Anesthesia professional (team lead): directs MH response, dantrolene initiation, physiologic stabilization. (mhaus.org)
  • Circulating nurse/runner: obtains MH cart, coordinates supplies/ice/cold saline, alerts additional staff. (aana.com)
  • Pharmacy/biomed: stock control, expiry tracking, refrigeration, and cart readiness audits. (Anesthesia Patient Safety Foundation)
  • MH crisis record: time of recognition, treatments, dantrolene total dose, temperature trend, labs, complications, ICU transfer. (mhaus.org)
  • MH cart check logs + restock logs. (mhaus.org)
  • Incident report + debrief record (Policy I8). (PMC)
  • Quarterly audit: MH cart readiness, expiry compliance, drill completion rates, and time-to-dantrolene review after events/drills. (Anesthesia Patient Safety Foundation)
  • MHAUS crisis management and MH cart recommendations. (mhaus.org)
I2

POLICY: Local Anesthetic Systemic Toxicity (LAST) + Lipid Rescue Kit Readiness + Dosing Card

To standardize prevention readiness and emergency response for LAST, ensuring immediate availability of a LAST rescue kit, rapid airway/ventilation support, seizure and cardiovascular management, and timely administration of 20% lipid emulsion per ASRA checklist. (ASRA Pain Medicine)

Applies to all locations where local anesthetics are used: OR, block areas, PACU, NORA, ED procedure areas (if applicable), including peripheral nerve blocks, neuraxial anesthesia, infiltration by surgeons, and topical local anesthetic use.

  • LAST: Systemic toxicity from local anesthetic exposure causing neurologic symptoms and/or cardiovascular collapse. (ASRA Pain Medicine)
  • LAST Rescue Kit: A dedicated kit containing lipid emulsion and cognitive aid/checklist for immediate response. (ASRA Pain Medicine)
  • 4.1 LAST cognitive aid (ASRA checklist) shall be available at point of care wherever local anesthetics are used. (ASRA Pain Medicine)
  • 4.2 A LAST rescue kit with in-date 20% lipid emulsion shall be immediately accessible in all block/anesthetizing areas. (ASRA Pain Medicine)
  • 4.3 LAST events/near-misses require incident reporting and debriefing per Policy I8. (PMC)

5.1 LAST Rescue Kit Contents (Minimum)

  • 20% lipid emulsion (quantity sufficient for initial bolus + infusion)
  • ASRA LAST checklist (laminated)
  • Weight-based dosing card (see 5.2)
  • Airway equipment access and suction/oxygen confirmation (local storage may vary) (ASRA Pain Medicine)

5.2 Lipid Rescue Dosing Card (20% Lipid Emulsion)

Use ASRA checklist dosing approach: (ASRA Pain Medicine)

  • Under 70 kg:
    • Bolus: ~ 1.5 mL/kg over 2–3 min
    • Infuse: ~ 0.25 mL/kg/min (consider pump if <40 kg)
    • If unstable: repeat bolus and double infusion
  • Over 70 kg:
    • Bolus: ~ 100 mL over 2–3 min
    • Infuse: ~ 250 mL over 15–20 min
    • If unstable: repeat bolus and double infusion
  • Key ACLS modifications from ASRA checklist:
    • Use smaller epinephrine doses (start <1 mcg/kg)
    • Avoid vasopressin, calcium channel blockers, beta blockers, and additional local anesthetic (ASRA Pain Medicine)

5.3 LAST Emergency Response (Minimum Algorithm)

  • Stop local anesthetic, call for help, bring LAST kit. (ASRA Pain Medicine)
  • Airway/oxygenation/ventilation: 100% O₂, support ventilation early.
  • Seizure management: benzodiazepine preferred; if only propofol available use low dose per checklist caution. (ASRA Pain Medicine)
  • Start lipid emulsion early per dosing card. (ASRA Pain Medicine)
  • Cardiovascular instability: follow modified resuscitation strategy per ASRA checklist; consider ECMO/CPB pathway if refractory. (ASRA Pain Medicine)
  • Transfer to ICU for monitoring after significant LAST (even if initially resolved), and document event.

5.4 Readiness Checks

  • Daily/shift: kit present, seal intact.
  • Monthly: expiry check, lipid quantity check, cognitive aid present, restock after use. (ASRA Pain Medicine)
  • Regional anesthesia lead/anesthesia leadership: kit standardization and audits.
  • Clinical staff: immediate recognition, response, and documentation per checklist. (ASRA Pain Medicine)
  • LAST event record (symptoms, timing, drugs/doses, lipid dosing, response, disposition). (ASRA Pain Medicine)
  • Kit check logs, restock logs.
  • Incident report + debrief record. (PMC)
  • Quarterly checks: kit readiness, staff training, and LAST drill participation; review any “time-to-lipid” delays. (ASRA Pain Medicine)
  • ASRA LAST Checklist and updates. (ASRA Pain Medicine)
I3

POLICY: Perioperative Anaphylaxis (OR/NORA/PACU) Crisis Response + Anaphylaxis Kit Readiness

To ensure immediate recognition and standardized management of perioperative anaphylaxis, including early epinephrine use, airway/ventilation support, rapid fluid resuscitation, identification/removal of triggers, structured documentation, post-event investigation planning, and kit readiness using established perioperative anaphylaxis guidance. (ANZCA)

Applies to all anesthesia/sedation locations (OR, NORA, PACU) and all staff involved in perioperative medication administration (anesthetics, antibiotics, neuromuscular blockers, antiseptics, latex exposure).

  • Perioperative anaphylaxis: life-threatening systemic hypersensitivity reaction during anesthesia/surgery/procedures requiring immediate treatment. (media.anzaag.com)
  • Anaphylaxis kit: immediate-use set of drugs/equipment for first-line management.
  • 4.1 A perioperative anaphylaxis cognitive aid shall be available in all anesthetizing areas and on resuscitation carts. (ANZCA)
  • 4.2 Anaphylaxis response shall include immediate epinephrine, airway management, IV fluids, and escalation pathways. (resus.org.uk)
  • 4.3 All suspected perioperative anaphylaxis events require incident reporting, debriefing (I8), and a follow-up plan for allergy evaluation and future anesthetic avoidance documentation. (ANZCA)

5.1 Anaphylaxis Kit Readiness (Minimum)

  • Epinephrine (suitable concentrations and delivery devices), syringes/needles
  • Large-bore IV supplies and rapid infusion capability
  • Airway equipment and suction access
  • Bronchodilator availability
  • Antihistamine and corticosteroid (adjuncts) per local formulary
  • Cognitive aid card (perioperative anaphylaxis management package) (ANZCA)
  • Checks: daily seal check; monthly expiry/full content check; restock after use.

5.2 Recognition Triggers

Consider anaphylaxis when rapid onset of airway/breathing/circulation compromise occurs, often with hypotension, bronchospasm, edema, rash (may be absent), and difficulty ventilating after exposure to likely triggers. (resus.org.uk)

5.3 Immediate Management (Minimum Algorithm)

  • Call for help, stop suspected trigger(s) if feasible (e.g., stop infusion).
  • Airway + 100% oxygen, support ventilation, treat bronchospasm.
  • Epinephrine is first-line (dose/route per institutional perioperative anaphylaxis guidance and patient severity). (resus.org.uk)
  • IV fluids (large volumes may be required) and hemodynamic support. (resus.org.uk)
  • Adjuncts: antihistamines, steroids, bronchodilator therapy as supportive measures (not substitutes for epinephrine). (resus.org.uk)
  • Escalate: activate code/rapid response if refractory shock/airway compromise; consider ICU transfer.
  • Post-event investigations: plan for appropriate blood tests (e.g., tryptase per local protocol) and allergy referral documentation. (ANZCA)
  • Anesthesia professional: leads acute management and documents suspected triggers and timeline.
  • Nursing/procedural team: supports stopping potential triggers, obtaining kit, fluids, and calling additional help.
  • Pharmacy/quality: supports post-event review and avoidance labeling.
  • Event timeline, suspected triggers (drug, latex, antiseptic), treatments (epi/fluids), response, disposition.
  • Incident report + debrief. (PMC)
  • Audit kit readiness and anaphylaxis drill participation; review any delays in epinephrine administration.
  • Perioperative anaphylaxis management guidance (ANZAAG/ANZCA) and Resuscitation Council UK anaphylaxis treatment guideline. (ANZCA)
I4

POLICY: Major Hemorrhage / Massive Transfusion Protocol (MTP) Activation and Escalation

To standardize rapid recognition and response to major hemorrhage, including timely activation of the Massive Transfusion Protocol (MTP), coordinated communication with blood bank, balanced component therapy, physiologic resuscitation (warming, calcium management, correction of coagulopathy), and safe escalation/transfer pathways, aligned with evidence-based best practices. (ACS)

Applies to all surgical/procedural areas (OR/NORA/PACU) and any location where life-threatening bleeding can occur, including obstetric, trauma, vascular, GI bleeding procedures, and postoperative hemorrhage.

  • Major hemorrhage: bleeding causing hemodynamic instability, rapidly falling Hb, or anticipated need for large volume transfusion.
  • Massive transfusion: commonly defined as large-volume transfusion (e.g., ≥10 units RBC in 24 hours) and is operationalized via protocol activation criteria. (معلومات التكنولوجيا الحيوية)
  • MTP: structured blood bank delivery and clinical management pathway. (ACS)
  • 4.1 The hospital shall maintain a written MTP with clear activation criteria, defined product delivery packs, responsibilities, and termination criteria. (ACS)
  • 4.2 MTP activation shall trigger immediate multidisciplinary escalation (anesthesia, surgery/proceduralist, nursing, blood bank, lab) and continuous reassessment. (ACS)
  • 4.3 All MTP activations require post-event review and debrief (I8) and data monitoring for improvement. (ACS)

5.1 Cognitive Aid + MTP Activation Card

Post the MTP activation steps and phone/pager numbers in OR core, PACU, NORA control areas, and on the hemorrhage cart.

5.2 Activation Criteria (Local Standard Must Define)

Activation should be based on clinical judgment and objective triggers (e.g., hemorrhagic shock, rapid ongoing blood loss, expected large transfusion requirement; trauma services may use scoring such as ABC in their system). (ACS)

5.3 Immediate Response Bundle (First Minutes)

  • Call for help and announce “MAJOR HEMORRHAGE / ACTIVATE MTP.”
  • Source control: surgical/procedural hemostasis steps escalate immediately.
  • Access: establish/confirm large-bore IV/rapid infuser readiness; consider arterial line.
  • Resuscitation priorities: prevent/treat hypothermia, acidosis, and coagulopathy (“lethal triad”).
  • Lab strategy: send ABG/VBG, lactate, CBC, coagulation parameters, fibrinogen; use viscoelastic testing if available (local choice). (ACS)

5.4 Blood Bank Coordination and Component Therapy

Blood bank delivers products per MTP pack design. Balanced component strategies are widely recommended; trauma best practices commonly support plasma:RBC ratios between 1:1 and 1:2 with platelet support incorporated by protocol design. (ACS)

Define termination criteria to stop MTP when bleeding controlled and physiology stabilizing. (ACS)

5.5 Critical Adjuncts (Local Protocol Must Specify)

Calcium monitoring/replacement, warming strategy, antifibrinolytic use (e.g., TXA) when indicated by local guideline, and management of hypocalcemia/hyperkalemia as clinically indicated.

5.6 Hemorrhage Cart Readiness (Minimum)

Rapid infuser/blood warmer access, pressure bags, large-bore cannulas, Level 1/rapid warming supplies, point-of-care testing access (if used), and MTP cognitive aid.

5.7 Post-Event

ICU transfer criteria, ongoing monitoring, documentation of total blood products and complications, debrief (I8), and data submission to MTP audit dashboard.

  • Anesthesia lead: resuscitation coordination, hemodynamic and temperature management, transfusion coordination with blood bank.
  • Procedural/surgical lead: hemorrhage source control and operative decisions.
  • Blood bank: product preparation/delivery and communication of inventory constraints. (ACS)
  • MTP activation time, product totals, labs, physiology, interventions, termination time, disposition. (ACS)
  • Quarterly review: time-to-MTP activation, time-to-first products, wastage, ratios achieved, hypothermia rate, and outcomes. (ACS)
  • ACS TQIP Massive Transfusion best practices; AABB massive transfusion resource; massive transfusion clinical summary. (ACS)
I5

POLICY: Difficult / Failed Airway Management (Adult + Pediatric) + Airway Cart Readiness

To standardize prevention and management of anticipated and unanticipated difficult airways, including early call for help, limited attempts, maintenance of oxygenation, structured escalation to supraglottic rescue and emergency front-of-neck access when required, and readiness of airway equipment carts and cognitive aids—aligned with major airway guidelines. (shanahq.com)

Applies to OR, NORA, PACU (re-intubation), ED resuscitation (if anesthesia responds), and critical airway events during transport. Applies to adult and pediatric patients, and to all anesthesia staff and supporting teams.

  • Difficult airway: difficulty with mask ventilation, supraglottic airway, tracheal intubation, or invasive airway rescue. (shanahq.com)
  • CICO/CICV: cannot intubate/cannot oxygenate scenario requiring immediate emergency pathway.
  • Cognitive aid: airway algorithm/poster used during crisis.
  • 4.1 Difficult airway planning and management shall follow a structured airway strategy emphasizing oxygenation and human-factors (role clarity, limiting attempts, early escalation). (shanahq.com)
  • 4.2 Difficult airway cognitive aids shall be available in all anesthetizing areas and on the difficult airway cart. (shanahq.com)
  • 4.3 A difficult airway cart shall be ready and immediately accessible per Section H2; daily readiness checks are required.
  • 4.4 Pediatric difficult airway events require pediatric-specific algorithms and equipment availability. (Difficult Airway Society)

5.1 Anticipated Difficult Airway (Planning)

Identify predictors and decide airway approach (including consideration of awake techniques when appropriate), equipment selection, backup plans, and call-for-help triggers consistent with ASA guidance. (shanahq.com)

5.2 Unanticipated Difficult Airway (Minimum Steps)

  • Maintain oxygenation; stop and reassess early.
  • Limit repeated attempts; change technique/operator and optimize conditions.
  • Escalate to supraglottic rescue if intubation fails and oxygenation deteriorates.
  • If oxygenation cannot be maintained: activate CICO pathway and perform emergency front-of-neck access per trained method. (shanahq.com)

5.3 Pediatric Pathway

Use pediatric difficult airway cognitive aids (age-appropriate) and pediatric equipment; recognize rapid desaturation risk in children and ensure immediate escalation capability. (Difficult Airway Society)

5.4 Airway Cart Readiness

Standardize cart contents (VL, SGA sizes, bougies, eFONA kit) and run daily seal checks + post-use restock.

5.5 Post-Event

Document airway difficulty details, devices used, number of attempts, complications, and create a “difficult airway alert” for future care. Debrief per I8.

  • Airway lead/anesthesia consultant on call: oversees algorithm adherence, training, and audit.
  • All anesthesia clinicians: follow standardized escalation and document clearly.
  • Airway note (attempts, devices, success, complications) and future alert; incident report for significant events. (shanahq.com)
  • Audit: cart readiness, cognitive aid availability, airway documentation completeness, and airway adverse event reviews.
  • ASA 2022 Difficult Airway Guidelines; DAS adult and pediatric difficult airway guidance. (shanahq.com)
I6

POLICY: Peri-Arrest / Code Blue in OR / NORA / PACU (Resuscitation Readiness + Cognitive Aids)

To ensure effective response to clinical deterioration and cardiac arrest in perioperative locations through standardized activation, role assignment, high-quality CPR, defibrillation readiness, airway management, and post-ROSC care aligned with AHA 2025 guidelines, with consistent equipment readiness and debriefing. (cpr.heart.org)

Applies to OR, NORA, PACU, transport corridors during perioperative transfers, and PACU-equivalent recovery areas.

  • Peri-arrest: rapidly deteriorating patient at high risk of arrest requiring immediate escalation.
  • Code Blue: institutional emergency response activation for cardiac arrest.
  • Cognitive aids: AHA algorithms and local perioperative arrest checklists. (cpr.heart.org)
  • 4.1 AHA resuscitation algorithms shall be available at point of care and on code carts. (cpr.heart.org)
  • 4.2 OR/NORA/PACU areas shall maintain immediate access to defibrillation and resuscitation equipment, with documented readiness checks. (cpr.heart.org)
  • 4.3 Perioperative teams shall conduct periodic drills and incorporate hot/cold debriefing after CPR events (Policy I8). (cpr.heart.org)

5.1 Activation and Team Roles

Activate Code Blue/RRT per hospital system immediately when criteria met.
OR roles: anesthesia typically leads airway/ventilation and rhythm management; nursing coordinates cart/meds; surgeon stops procedure and manages bleeding source if present.

5.2 Immediate Actions (Cardiac Arrest)

Start high-quality CPR, attach defibrillator/monitor, follow AHA algorithm for shockable/non-shockable rhythms, and address reversible causes. (cpr.heart.org)

5.3 Peri-Arrest (Deterioration)

Early recognition and escalation; treat causes (hypoxia, hypotension, arrhythmia, hemorrhage, anaphylaxis, MH/LAST) and mobilize resources before arrest.

5.4 Location-Specific Considerations

  • NORA: limited access/space; ensure extraction plan for MRI; confirm defib access.
  • PACU: common causes include airway obstruction/opioid respiratory depression; prioritize airway support and monitoring escalation.

5.5 Post-ROSC and Transfer

Stabilize airway/ventilation and hemodynamics; transfer to ICU per post-arrest pathway; document full timeline.

5.6 Code Cart Readiness

Daily seal check; monthly full inventory; defib functional check per biomedical schedule.

  • Resuscitation committee / anesthesia leadership: training and QI oversight.
  • All staff: activate emergency response without delay.
  • Code record (rhythm, shocks, meds, CPR times), post-ROSC plan, ICU transfer note.
  • Arrest drill compliance, time-to-defib (shockable rhythms), outcome metrics, and debrief completion rate. (cpr.heart.org)
  • AHA 2025 CPR/ECC guideline resources and algorithms; AHA 2025 highlights including clinical debriefing. (cpr.heart.org)
I7

POLICY: OR Fire / Laser / Oxygen-Enriched Environment Safety (Prevention + Response)

To prevent and manage surgical fires by standardizing risk assessment, control of the fire triad (oxidizers, ignition sources, fuels), safe oxygen delivery practices, laser/electrocautery precautions, and an immediate response algorithm for airway and field fires, supported by cognitive aids and readiness checks. (Anesthesia Patient Safety Foundation)

Applies to OR and procedural rooms (including NORA) where ignition sources (electrocautery/laser), fuels (drapes, alcohol prep), and oxidizers (oxygen, nitrous oxide) may coexist.

  • Surgical fire triad: oxidizer + ignition source + fuel. (Anesthesia Patient Safety Foundation)
  • Oxygen-enriched environment: increased local oxygen concentration near surgical field, increasing fire risk. (Anesthesia Patient Safety Foundation)
  • Airway fire: fire involving airway device/oxygen in airway (highest severity).
  • 4.1 A fire risk assessment shall occur for cases with elevated risk (head/neck, airway surgery, laser use, open oxygen delivery), and the team shall agree on preventive measures. (Anesthesia Patient Safety Foundation)
  • 4.2 Oxygen delivery near ignition sources shall be minimized; open-source oxygen concentration should be limited for high-risk cases when clinically feasible (commonly cited target ≤30% in high-risk situations). (Anesthesia Patient Safety Foundation)
  • 4.3 Fire response steps shall be posted as cognitive aids and practiced in drills. (Anesthesia Patient Safety Foundation)

5.1 Prevention Bundle

  • Oxidizers:
    • Avoid oxygen pooling under drapes; use scavenging/venting; consider closed systems when appropriate. (Anesthesia Patient Safety Foundation)
    • For high-risk cases, limit open oxygen delivery concentration where feasible. (Anesthesia Patient Safety Foundation)
  • Ignition sources:
    • Cautery/laser safety time-out: announce “laser/cautery on,” coordinate oxygen reduction before activation. (Anesthesia Patient Safety Foundation)
  • Fuels:
    • Allow alcohol skin prep to dry fully; manage sponges/drapes; use wet sponges around airway when appropriate. (bjaed.org)

5.2 Immediate Response Algorithm

  • A. If fire in surgical field (non-airway):
    • Stop procedure, announce “FIRE.”
    • Stop oxidizer flow where safe; remove burning materials.
    • Extinguish with saline/water or extinguisher as appropriate; assess patient injury; resume only after safety confirmed. (Anesthesia Patient Safety Foundation)
  • B. If airway fire suspected:
    • Immediately stop gases, remove airway device, extinguish fire with saline, re-establish ventilation, assess airway injury and plan bronchoscopy per clinical judgment. (bjaed.org)

5.3 Fire Equipment Readiness

Confirm location and accessibility of CO₂ extinguisher and saline/water source; include fire cognitive aid in OR safety binder; drill at defined intervals.

5.4 Post-Event

Treat injuries, document, incident report, and debrief (I8). (PMC)

  • Surgeon/proceduralist: ignition source control.
  • Anesthesia professional: oxidizer control/oxygen strategy and airway management.
  • Nursing team: fuel management (prep/drapes) and extinguisher access.
  • Fire risk assessment documentation for high-risk cases; event report and actions taken.
  • Fire drill completion rate; audit oxygen practices in high-risk cases; review any fire/near-miss events.
  • APSF OR fire safety resources and oxygen-enriched environment recommendations; BJA Education review on surgical fire prevention/response. (Anesthesia Patient Safety Foundation)
I8

POLICY: Post-Event “Hot” Debrief + “Cold” Debrief, Documentation, and Learning Loop

To ensure that every significant perioperative critical event (MH, LAST, anaphylaxis, hemorrhage/MTP, difficult airway, code blue, OR fire) triggers structured debriefing and documentation that supports patient safety, system learning, and staff wellbeing, incorporating immediate (hot) and delayed (cold) debriefing as recommended in modern resuscitation systems guidance. (cpr.heart.org)

Applies to OR, NORA, PACU, and transport-related critical events and near-misses, including events with high harm potential even if harm did not occur.

  • Hot debrief: brief, structured discussion immediately after event stabilization (minutes). (cpr.heart.org)
  • Cold debrief: deeper review within days (case review/QI meeting) to address system actions, data, and follow-up. (cpr.heart.org)
  • Action log: documented improvement actions with owners and due dates.
  • 4.1 A hot debrief shall be conducted after critical events when operationally feasible, before team dispersal. (PMC)
  • 4.2 A cold debrief/system review shall occur for significant events within a defined timeframe (e.g., 72 hours to 2 weeks) under governance of anesthesia/quality leadership. (cpr.heart.org)
  • 4.3 Debrief outcomes shall generate documented corrective actions, and completion shall be tracked. (PSNet)

5.1 Triggers for Debrief (Minimum)

Code blue/peri-arrest, MH, LAST, anaphylaxis, major hemorrhage/MTP, unplanned re-intubation, CICO/eFONA, OR fire, unplanned ICU transfer from PACU, severe medication error, or any high-potential near-miss.

5.2 Hot Debrief Script (5–10 minutes)

  • Facts: what happened (timeline highlights).
  • What went well: teamwork, early recognition, equipment readiness.
  • What could improve: communication, role clarity, delays, missing items.
  • Safety actions now: equipment restock, labeling of patient risks, immediate staff support needs.
  • Assign owners: who will file incident report, who will restock carts, who will schedule cold debrief. (PMC)

5.3 Cold Debrief (System Review)

  • Review data: monitor trends, timing of key interventions (time-to-dantrolene/lipid/epi/defib/MTP).
  • Identify root contributors: training gaps, stocking/maintenance, environment constraints, documentation issues.
  • Define actions: policy update, drill schedule, cart redesign, checklist updates, simulation training. (PMC)

5.4 Staff Support

Offer peer support resources after distressing events; normalize emotional impact and provide follow-up routes. (PMC)

5.5 Documentation Package

  • Debrief form: date/time, participants, key lessons, action items (owner + due date).
  • Link to incident report number and equipment restock confirmation.
  • Event leader (anesthesia consultant or designee): initiates hot debrief.
  • Quality/safety lead: schedules cold debrief and tracks action closure.
  • Unit leadership: ensures carts are restocked and returned to service.
  • Hot debrief note, cold debrief minutes, action log, incident report, and audit dashboard updates. (PSNet)
  • Track: percentage of eligible events with hot debrief completed, time to cold debrief, and action closure rate. Include CPR debrief compliance if applicable. (cpr.heart.org)
  • AHA 2025 guideline highlights recommending immediate and delayed debriefing after CPR; perioperative critical event debriefing literature; AHRQ PSNet learning value of debriefing. (cpr.heart.org)

💬 التعليقات والملاحظات

أضف تعليقك

التقييم: ★★★★★